Skip to content

Clinical trials

Phase 2 Lymphoma, Follicular trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Phase: Phase 2 Country / region: Australia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20121
20132
20141
20151
20162
20171
20184
20193
20211
20232
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting5
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC3
Novartis Pharmaceuticals3
Olivia Newton-John Cancer Research Institute2
Pfizer2
Regeneron Pharmaceuticals2
AstraZeneca1
Australasian Leukaemia and Lymphoma Group1
BeiGene1
Celgene1
Fondazione Italiana Linfomi - ETS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular23
Lymphoma4
Lymphoma, Non-Hodgkin4
Lymphoma, B-Cell3
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Mantle-Cell3
Recurrence3
Dermatitis, Atopic2
Alopecia Areata1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.